FOCUS ON
A PATH FORWARD
CRYSVITA® (burosumab-twza) is the only FDA-approved medicine for adults and children 6 months of age and older with X-linked hypophosphatemia (XLH). CRYSVITA works by targeting the underlying cause of this progressive and lifelong disease.
Why CRYSVITAliving with XLH